Julia Ząber

Julia Ząber

Auto-generated profile, based on publicly available information

Julia Ząber

Military Clinical Hospital with Polyclinic SPZOZ, Wrocławska 1-3, 30-901 Kraków

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2025 in Advancements of Microbiology
Verified
Journal Article
Open access
PDF file
UDUrszula Durlak
Urszula Durlak
WSWiktor Szczuciński
Wiktor Szczuciński
ZWZuzanna Wyleciał
Zuzanna Wyleciał
JZJulia Ząber
Julia Ząber
PKPaweł Marcin Krzyściak
Paweł Marcin Krzyściak
Oral cancer, predominantly oral squamous cell carcinoma (OSCC), is a multifactorial disease influenced by genetic, environmental, and microbial factors. Among the emerging contributors to oral carcinogenesis, Fusobacterium nucleatum and Porphyromonas gingivalis , two Gram-negative anaerobic bacteria that reside in the human oral cavity as part of the normal microbiota, have gained attention for their pathogenic roles. Both species play key roles in periodontal disease and exhibit significant tumour-promoting activities through distinct and synergistic mechanisms. They modulate the tumor microenvironment by promoting the release of pro-inflammatory cytokines, facilitating immune evasion, and contributing to microbial dysbiosis. Clinical studies have identified their presence in OSCC tissues, correlating with advanced tumor stages, lymph node metastasis, and poor prognosis. Their involvement underscores the critical interplay between oral microbiota and host-pathogen interactions in cancer development. This review highlights the molecular mechanisms through which F. nucleatum and P. gingivalis contribute to oral carcinogenesis, emphasizing the need for further research to explore their diagnostic and therapeutic potential in oral cancer management. Addressing these microbial drivers could pave the way for innovative strategies in cancer prevention and treatment.

7 July 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MGMarcelina Guzik
Marcelina Guzik
ZWZuzanna Wyleciał
Zuzanna Wyleciał
PDPatryk Dąbrowski
Patryk Dąbrowski
JZJulia Ząber
Julia Ząber
Introduction and Purpose:Sleep is a fundamental component of performance, recovery, and overall health in professional athletes. However, sleep disturbances—including insufficient duration, poor quality, and insomnia—are highly prevalent in this population due to factors such as early-morning training, late-evening competitions, transmeridian travel, and psychological stress. This review aims to provide a comprehensive summary of current knowledge regarding sleep monitoring techniques and evidence-based interventions to improve sleep in elite athletes. Methods:We conducted a structured literature search in PubMed, Embase, and UpToDate through May 2025. Eligible studies included systematic reviews, randomized controlled trials, observational studies, and consensus guidelines focusing on sleep in professional, elite, or Olympic-level athletes. Search terms included combinations of "sleep," "athletes," "interventions," and "performance." Findings were narratively synthesized under thematic headings. Current State of Knowledge:Up to 60% of elite athletes report poor sleep quality, and 27–37% exhibit insomnia symptoms during competition periods. Key contributors include circadian disruption, high training loads, pre-competition anxiety, and environmental/lifestyle factors. Assessment tools such as actigraphy and the Athlete Sleep Screening Questionnaire (ASSQ) are validated and widely used. Non-pharmacological strategies, especially sleep hygiene education, sleep extension, strategic napping, CBT-I, and light exposure demonstrate positive effects on sleep duration, quality, and performance. Melatonin shows potential for managing jet lag, though evidence in athletic settings remains limited. Sedatives are rarely studied and should be used with caution. Conclusions:Sleep problems are common and impactful in elite sport. Personalized, non-pharmacological approaches should be prioritized, while further research is needed to refine and validate targeted interventions.

31 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
ZWZuzanna Wyleciał
Zuzanna Wyleciał
EPEliza Pyla
Eliza Pyla
WZWiktoria Zamachowska
Wiktoria Zamachowska
JZJulia Ząber
Julia Ząber
Introduction and purpose: Shingles, or herpes zoster, is a painful condition caused by the reactivation of the varicella-zoster virus, the same virus responsible for chickenpox. Vaccination is the most effective way to prevent shingles and its complications, including postherpetic neuralgia (PHN), a chronic and debilitating nerve pain condition. Vaccination is the most effective way to prevent shingles and its associated complications. This article provides an overview of current recommendations for shingles vaccination, including who should be vaccinated, the available vaccines, and key considerations. Materials and methods: A literature search was conducted by analysing scientific articles published in Google Scholar, PubMed, and UpToDate using keywords included: shingles, vaccination, varicella-zoster virus, infection. We also searched current recommendations of Centers for Disease Control and Prevention. Description of the state of knowledge: Shingles is a common condition, especially in older adults and those with weakened immune systems. While the disease itself can cause significant pain and discomfort, the risk of complications increases with age and other health conditions. Vaccination offers robust protection against shingles and its complications, reducing the overall health burden. Consulting a healthcare provider is advised to determine the best vaccination approach based on individual health conditions. Conclusion: Vaccination against shingles is a critical preventive measure for adults, particularly those aged 50 and older or individuals with weakened immune systems. Shingrix is the recommended vaccine due to its high efficacy and long-lasting protection. Patients should discuss their vaccination plans with healthcare provider to determine the optimal timing and ensure it aligns with their health needs. By staying proactive, individuals can significantly reduce their risk of shingles and enjoy better long-term health.

30 September 2025 in Pneumon
Verified
Journal Article
Open access
JZJulia Ząber
Julia Ząber
ZWZuzanna Wyleciał
Zuzanna Wyleciał
We present a case of a 65-year-old Caucasian man with a six-month history of persistent non-productive cough, weight loss, and decreased exercise tolerance. Laboratory tests performed revealed significant eosinophilia in peripheral blood. Chest computed tomography identified extensive peripheral...

1 June 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JZJulia Ząber
Julia Ząber
ZWZuzanna Wyleciał
Zuzanna Wyleciał
PDPatryk Dąbrowski
Patryk Dąbrowski
MGMarcelina Guzik
Marcelina Guzik
EPEliza Pyla
Eliza Pyla
Introduction and purpose: Adrenal incidentalomas are increasingly detected due to the widespread use of advanced imaging techniques, presenting a growing clinical challenge. These adrenal masses, often discovered unintentionally, necessitate careful evaluation to differentiate between benign and malignant lesions, as well as hormonally active and inactive tumors. Despite a shared clinical concern, the management of adrenal incidentalomas varies across European countries, reflecting differences in healthcare systems, access to resources, and interpretation of evidence-based practices. This article aims to provide an overview of the current guidelines adopted by various European nations, highlighting areas of consensus and divergence, and exploring their implications for clinical practice and patient outcomes. Materials and methods: A literature search was conducted by analysing scientific articles published in Google Scholar, PubMed, and UpToDate using keywords included: incidentaloma, adrenal glands, hormonal activity, malignancy. We also searched current recommendations of The Endocrine Society Clinical Practice Guidelines. Description of the state of knowledge: Adrenal incidentalomas are asymptomatic adrenal masses detected incidentally during imaging studies performed for unrelated reasons. The clinical importance of these lesions lies in their potential for hormonal activity and malignancy. This article aims to evaluate the current strategies and guidelines for hormonal assessment in patients with adrenal incidentalomas. A systematic hormonal workup is essential to identify subclinical hormone secretion, particularly autonomous cortisol secretion, pheochromocytoma, and primary aldosteronism. Conclusion: Timely and accurate hormonal evaluation is crucial for risk stratification and guiding management decisions, including surveillance or surgical intervention. This assessment is key to preventing potential complications and improving patient outcomes.

8 January 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
ZWZuzanna Wyleciał
Zuzanna Wyleciał
JZJulia Ząber
Julia Ząber
WZWiktoria Zamachowska
Wiktoria Zamachowska
Introduction and purpose: Lyme borreliosis, caused by Borrelia burgdorferi sensu lato complex, is the most common vector-borne disease in Europe. Transmitted by Ixodes ticks, its prevalence is increasing due to climate change, expanded tick habitats, and improved diagnostic awareness. Consequently, unified and evidence-based management guidelines are critical to ensure consistent diagnosis and treatment across European countries. This article provides an overview of current guidelines from 2023 for the management of Lyme borreliosis in Europe. Materials and methods: A literature search was conducted by analysing scientific articles published in Google Scholar, PubMed, and UpToDate using keywords included: Lyme disease; guidelines; Borrelia burgdorferi; management. We also searched current guidelines of Polish Society of Epidemiology and Infectious Diseases and recommendations from other European countries. Description of the state of knowledge: There are 3 stages of Lyme disease: early localized, early disseminated and late. Clinical diagnosis is based on symptoms, history of tick exposure, and observation of erythema migrans. To confirm Lyme disease, laboratory tests must also be performed. Lyme borreliosis is typically treated with antibiotics depending on the character. Conclusion: European guidelines for Lyme borreliosis emphasize early diagnosis and appropriate antibiotic therapy based on disease stage. Preventive measures and public health initiatives are essential to reduce the disease burden. While current guidelines ensure effective management, continued harmonization and advancements in diagnostics, treatment, and vaccine development will further enhance Lyme borreliosis care across Europe. Keywords: Lyme disease; guidelines; Borrelia burgdorferi; management.